Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

23.43
Delayed Data
As of Feb 17
 -0.14 / -0.59%
Today’s Change
20.39
Today|||52-Week Range
39.85
-2.65%
Year-to-Date

Today’s Trading

Previous close23.57
Today’s open23.35
Day’s range23.11 - 23.71
Volume869,686
Average volume (3 months)1,255,832
Market cap$2.8B
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-96.56%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book3.94

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+0.19+0.35%
JUNOJuno Therapeutics In...-0.10-0.43%
BLUEbluebird bio Inc+0.55+0.72%
EXASExact Sciences Corp-0.26-1.29%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs